Novartis AG (NVS)

Publicly reported company facts and saved market data for Novartis AG (NVS), with sources and as-of times. Saved data is not a live quote.

Company profile

is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 300 million people worldwide.Reimagine medicine with us: Visit us at https://www.novartis.

Company facts

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $303.7B · as of 2026-10-30
Incorporated in: Switzerland
Company website: www.novartis.com
Exchange: NYSE

Saved quote

Saved snapshot, not a real-time quote. Check the market time before relying on it.

Last reported price: $161.1
Reported change: +0.00%
Reported volume: 3,152,733
Latest market time: 2026-10-30 16:22 ET

Float and shares outstanding

NVS float references and SEC-reported shares outstanding
Measure	Shares	As of	Source and basis
Shares outstanding (O/S)	1,908,151,679	2025-12-31	SEC 20-F filing · filed 2026-02-04 Historical: the latest SEC-reported figure is more than six months old.

Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.

Recent daily sessions

The 10 most recent saved daily sessions, through 2026-10-26. Daily OHLC and volume; not real-time.

NVS daily open, high, low, close and volume
Date	Open	High	Low	Close	Volume
2026-10-26	153.53	154.24	152.02	153.81	2,816,388
2026-10-23	156.08	156.08	149.17	151.12	4,358,805
2026-10-22	154.90	157.10	154.38	156.27	2,081,375
2026-10-21	153.12	154.12	152.93	153.93	1,019,112
2026-10-20	152.15	153.68	151.95	153.64	1,356,945
2026-10-19	150.22	150.90	149.62	150.20	1,866,732
2026-10-16	150.65	151.74	150.23	150.62	1,729,385
2026-10-15	150.32	151.83	149.63	150.38	2,090,443
2026-10-14	144.35	147.16	144.17	146.88	1,647,419
2026-10-13	145.18	145.24	142.31	142.41	1,841,488

Dilution timeline

As of 2026-10-27T10:00:26.556698+00:00

2026-03-17 · 424B5 · Prospectus filed
2026-03-17 · FWP · Free writing prospectus filed
2026-03-16 · 424B5 · Prospectus filed
2025-11-04 · 424B5 · Prospectus filed
2025-11-04 · FWP · Free writing prospectus filed
2025-11-03 · 424B5 · Prospectus filed
2024-09-17 · 424B5 · Prospectus filed
2024-09-16 · 424B5 · Prospectus filed
2024-09-16 · F-3ASR · Shelf registration filed
2024-09-16 · FWP · Free writing prospectus filed

Parsed share counts, prices and warrant terms require Plus or above. Explore plans

Research this company

FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.